🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/03/2003 | 48,45 | 48,72 | 47,61 | 48,44 | -0,82% | 2,28% | 6.114.870 |
| 10/03/2003 | 49,19 | 49,54 | 48,65 | 48,85 | -2,23% | 1,82% | 4.710.760 |
| 07/03/2003 | 48,76 | 50,29 | 48,73 | 49,96 | +0,79% | 3,19% | 5.362.616 |
| 06/03/2003 | 49,26 | 50,09 | 48,92 | 49,57 | +0,15% | 2,36% | 5.663.497 |
| 05/03/2003 | 48,62 | 49,73 | 48,56 | 49,49 | +0,50% | 2,41% | 7.118.854 |
| 04/03/2003 | 50,05 | 50,05 | 49,25 | 49,25 | -1,68% | 1,60% | 5.233.188 |
| 03/03/2003 | 50,91 | 51,26 | 49,73 | 50,09 | -0,49% | 3,00% | 4.775.107 |
| 28/02/2003 | 50,38 | 50,60 | 49,99 | 50,33 | -0,09% | 1,21% | 5.881.166 |
| 27/02/2003 | 49,71 | 50,94 | 49,71 | 50,38 | +1,34% | 2,48% | 5.010.383 |
| 26/02/2003 | 50,33 | 50,89 | 49,46 | 49,71 | -1,23% | 2,84% | 4.807.595 |
| 25/02/2003 | 49,62 | 50,61 | 49,24 | 50,33 | +0,55% | 2,77% | 5.411.558 |
| 24/02/2003 | 50,94 | 51,05 | 49,62 | 50,06 | -2,51% | 2,81% | 5.878.232 |
| 21/02/2003 | 50,72 | 51,91 | 50,48 | 51,35 | +0,81% | 2,82% | 5.254.882 |
| 20/02/2003 | 51,81 | 52,07 | 50,73 | 50,94 | -1,80% | 2,60% | 4.237.588 |
| 19/02/2003 | 52,40 | 52,55 | 51,36 | 51,87 | -0,98% | 2,28% | 4.069.279 |
| 18/02/2003 | 52,32 | 52,91 | 51,96 | 52,39 | +1,84% | 1,82% | 4.822.058 |
| 14/02/2003 | 50,19 | 51,52 | 50,19 | 51,44 | +2,49% | 2,64% | 6.044.026 |
| 13/02/2003 | 50,50 | 50,62 | 49,24 | 50,19 | -1,41% | 2,74% | 4.709.607 |
| 12/02/2003 | 51,62 | 51,64 | 50,71 | 50,91 | -1,22% | 1,81% | 4.664.753 |
| 11/02/2003 | 52,34 | 52,67 | 51,39 | 51,54 | -0,72% | 2,44% | 4.685.922 |
| 10/02/2003 | 51,13 | 52,08 | 50,67 | 51,91 | +1,57% | 2,76% | 5.964.797 |
| 07/02/2003 | 51,92 | 52,00 | 50,38 | 51,11 | -1,56% | 3,12% | 5.400.134 |
| 06/02/2003 | 51,67 | 52,59 | 51,38 | 51,92 | -0,46% | 2,33% | 5.942.160 |
| 05/02/2003 | 52,91 | 53,35 | 51,92 | 52,16 | -0,35% | 2,71% | 5.490.577 |
| 04/02/2003 | 52,58 | 52,67 | 52,00 | 52,34 | -1,81% | 1,27% | 5.982.403 |
| 03/02/2003 | 52,86 | 53,73 | 52,73 | 53,30 | +0,85% | 1,90% | 5.531.030 |
| 31/01/2003 | 51,88 | 53,16 | 51,69 | 52,85 | +1,61% | 2,83% | 5.904.118 |
| 30/01/2003 | 53,24 | 53,37 | 51,56 | 52,01 | -1,59% | 3,39% | 6.267.040 |
| 29/01/2003 | 51,67 | 53,29 | 51,53 | 52,85 | +1,82% | 3,42% | 6.969.305 |
| 28/01/2003 | 50,55 | 52,57 | 50,36 | 51,91 | +5,10% | 4,36% | 10.412.614 |